Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.

Accepted 2025-02-27 00:00:00 ET · period of report 2024-05-17 · accession 0001140361-25-006272 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-02-27	2024-05-17+	RCKT	Schwartz Jonathan David	See Remarks	S - Sale	$14.84	-15.1K	166.9K	-8%	-$224.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-02-25	S	D	6,532	$10.58	237,638	D	—	—	(F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. (F3) Inclusive of the acquisition of 80,318 RSUs that convert to common stock on a one-for-one basis, as reported on the Reporting Person's Form 4 filed on 02/13/2025.
2	Common	Common Stock	2024-11-21	S	D	3,097	$13.05	163,852	D	—	—	(F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
3	Common	Common Stock	2024-05-17	S	D	2,754	$23.35	169,659	D	—	—	(F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
4	Common	Common Stock	2024-08-16	S	D	2,710	$18.50	166,949	D	—	—	(F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.